MAAT INDEX

CLAIM #48447 · Pfizer Inc (PFE) · 2024Q3 earnings call · Oct 29, 2024 · due Apr 30, 2026

If Daniel moves fast based on what we know right now, we should be the second oral into the market, provided that the first one will be successful and the other ones will not come before us.

Albert Bourla · CEO

PENDING
graded after results covering Apr 30, 2026 are reported

Verify independently

SEC filings for PFE · Claim quote is verbatim from the 2024Q3 earnings call.